Clinical Trial Update: Analytical Treatment Interruption in a Patient With HIV Post Allogeneic Stem Cell Transplantation From a CCR5 delta32 Homozygous Donor [NA]

View source ↗

Summary

Clinical trial update describing analytical treatment interruption in an HIV-1 infected patient who underwent allogeneic stem cell transplantation from a CCR5 d…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Snippet

Sponsor: University of Kansas Medical Center | Conditions: HIV-1-infection | NA | Status: NOT_YET_RECRUITING